AKR1B10 has a very high catalytic efficiency for all-trans-retinaldehyde and a more specific tissue expression (mostly in the gastrointestinal, GI, tract), although it is overexpressed in several cancer types and skin diseases. This evidence concerns the gene AKR1B10 and cancer.